Kanika Bahl

Kanika is CEO and President of Evidence Action where she has been on the Board since 2015. She is also on the Board of TechnoServe and a Trustee of Anthropic's Long-Term Benefit Trust. Previously she served as Managing Director at Results for Development (R4D), where she established and led the Market Dynamics practice. The practice has increased access to products such as childhood pneumonia treatments and malaria bed nets for millions of individuals in Africa and Asia. Prior to R4D, Kanika served as an Executive Vice President at the Clinton Health Access Initiative (CHAI) where she established greenfield operations in 17 African countries. She launched and led a $400M, 33-country public-private facility focused on driving access to new HIV/AIDS drugs and diagnostics. She received her MBA from the Stanford Graduate School of Business and her BA in Mathematical Economics from Rice University.